MSN Laboratories | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for MSN Laboratories

Team Bitscale

26 Mar 2026 — 1 min read

MSN Laboratories

Overview

MSN Laboratories, part of the MSN Group, is a research-based pharmaceutical company established in 2003 and headquartered in Hyderabad, India. The company focuses on developing and manufacturing high-quality, affordable medicines for global markets. With advanced manufacturing and R&D facilities in India and the USA, MSN Laboratories employs thousands of professionals, including a significant number dedicated to research and development.

MSN Laboratories has experienced substantial growth, with revenues rising from $22 million in 2005 to between $670-750 million in recent fiscal years. The company holds a prominent position in active US Drug Master File filings and has filed numerous national and international patent applications. Its diverse portfolio covers over 450 APIs and more than 300 finished dosages across 35 therapeutic areas, such as Oncology, Cardiology, and Diabetes. The company’s mission is to make high-quality medicines accessible worldwide through innovative drug discovery, development, and production.

Basic Information

Industry	pharmaceuticals
Founded	2003
Revenue	750M
Headquarters	11, Hyderabad, Telangana, 500081, India
Languages	English

Contact Details

Key Focus Areas & Initiatives

API development
Branded generics
CDMS
Finished dosage formulations
Research and development
Pharmaceutical manufacturing
Medical innovations

Technologies Used

AI
Activa
Amazon AWS
Apache
Bootstrap Framework
Cloudflare DNS
Concur
Flow
Gem
Gmail
GoDaddy Hosting
Google Apps
Google Font API
Google translate API
Google translate widget
Microsoft Active Directory Federation Services
Microsoft Office
Microsoft Windows Server 2012
Mobile Friendly
React
SAP
SAS Enterprise Guide
Salesforce
Salesforce CRM Analytics
Slack
Tegrity
Thermo Scientific Chromeleon Chromatography Data System (CDS)
YouTube

Affiliated Organizations & Regional Branches

Clay API Limits, Authentication & Rate Limits Explained

Your enrichment workflow ran perfectly on 50 test records. Then you pointed it at 10,000 contacts and everything collapsed: 429 errors, duplicate CRM writes, and a credit balance that evaporated overnight. The Clay API usually is not the root cause. The root cause is treating authentication, rate limits, and

GTM Data Stack for US Outbound Teams

Outbound has changed. Spray-and-pray cadences that worked five years ago now burn through contact lists, damage sender reputation, and leave revenue teams short on pipeline. What separates high-performing US outbound teams in 2026 is not effort or headcount. It is the quality, governance, and architecture of the GTM Data Stack.

GTM Automation for VC/PE-backed Startups

Every board deck at a VC or PE-backed startup tells the same story: aggressive revenue targets, intense board pressure after funding, and the need to make every dollar of runway count. Headcount alone doesn't fix pipeline math, especially with lean SDR teams. GTM automation (systematically automating target account

B2B Email List Providers Playbook: Build Clean, Compliant Lists That Actually Convert

In B2B sales, your email list is either a growth engine or a money pit. An outdated, irrelevant, or non-compliant database does not just fail to convert, it harms deliverability, wastes rep time, and increases risk across your GTM motion. That is why choosing B2B Email List Providers (and setting